Literature DB >> 28839683

The future of gastroenterology: patient choice, patient voice.

Richard Driscoll1, Peter Canham1.   

Abstract

The policy context for patient choice and public and patient involvement (PPI) in the NHS is set out. Both have become increasingly prominent since 2000. A series of NHS systems and policies have been put in place to enable greater patient choice in the belief that the exercise of choice by patients will influence providers to improve quality. This has had some success in elective surgery. One focus has been the publication of outcome data and this may have led to quality improvement through the inherent competitiveness of professionals and institutions. PPI has suffered from a series of unsuccessful reorganisations of patient involvement organisations but has ensured that most health bodies include patient representatives. Capturing patient experience and providing information to enable patient choice have been constantly developed over this time. A particular framework developed by Angela Coulter is used to review current levels of patient engagement in Inflammatory Bowel Disease (IBD), exploring the extent to which patient choice and patient voice are supported and enhanced within current IBD services locally and in national IBD strategy.1 A 2017 vision of the way in which IBD services might maximise patient choice and patient voice is put forward, based on the adoption of present good practice and current service developments, followed by a few rather more radical thoughts about possibilities for after 2017.

Entities:  

Year:  2012        PMID: 28839683      PMCID: PMC5551944          DOI: 10.1136/flgastro-2011-100058

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  4 in total

1.  Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis.

Authors:  Gilaad G Kaplan; Ellen P McCarthy; John Z Ayanian; Joshua Korzenik; Richard Hodin; Bruce E Sands
Journal:  Gastroenterology       Date:  2008-01-10       Impact factor: 22.682

2.  Physician groups' use of data from patient experience surveys.

Authors:  Mark W Friedberg; Gillian K SteelFisher; Melinda Karp; Eric C Schneider
Journal:  J Gen Intern Med       Date:  2010-12-15       Impact factor: 5.128

Review 3.  Review article: explaining risks of inflammatory bowel disease therapy to patients.

Authors:  C A Siegel
Journal:  Aliment Pharmacol Ther       Date:  2010-10-26       Impact factor: 8.171

4.  A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease.

Authors:  A P Kennedy; E Nelson; D Reeves; G Richardson; C Roberts; A Robinson; A E Rogers; M Sculpher; D G Thompson
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.